Clinical Trials
7 trialsNCT07020117 2026-04-21
A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors
Aktis Oncology, Inc.
Phase 1 Recruiting
NCT06448793 2025-12-04
Patient and Physician Preference Study in Resectable, Non-small Cell Lung Cancer Treatments
Bristol-Myers Squibb
Recruiting
NCT02392455 2025-07-28
VARGADO - Vargatef in 2nd-line Therapy of Non-Small Cell Lung Cancer (NSCLC)
Boehringer Ingelheim
Completed
NCT03761901 2020-05-08
REVEAL
AstraZeneca
Completed
NCT01154140 2017-11-06
PROFILE 1014
Pfizer
Phase 3 Completed
NCT01929200 2015-05-22
Icotinib as Adjuvant Therapy in Treating Non-small-cell Lung Cancer Patients With Positive EGFR Mutation
Betta Pharmaceuticals Co., Ltd.
Phase 2 Unknown
NCT00827177 2014-01-24
Dose Escalation Study of ARQ 197 in Combination With Sorafenib in Adult Patients With Advanced Solid Tumors
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)
Phase 1 Completed